ATE220110T1 - Assays und reaganzien zur identifizierung von fungiziden wirkstoffen und ihre verwendungen - Google Patents

Assays und reaganzien zur identifizierung von fungiziden wirkstoffen und ihre verwendungen

Info

Publication number
ATE220110T1
ATE220110T1 AT97921143T AT97921143T ATE220110T1 AT E220110 T1 ATE220110 T1 AT E220110T1 AT 97921143 T AT97921143 T AT 97921143T AT 97921143 T AT97921143 T AT 97921143T AT E220110 T1 ATE220110 T1 AT E220110T1
Authority
AT
Austria
Prior art keywords
reagants
assay
active ingredients
fungicidal active
relates
Prior art date
Application number
AT97921143T
Other languages
English (en)
Inventor
Vivian Berlin
David E Levin
Yoshikazu Ohya
Original Assignee
Mitotix Inc
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/631,319 external-priority patent/US6117641A/en
Application filed by Mitotix Inc, Univ Johns Hopkins filed Critical Mitotix Inc
Application granted granted Critical
Publication of ATE220110T1 publication Critical patent/ATE220110T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/40—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Candida
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6895—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
    • G01N2333/39—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts
    • G01N2333/40—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts from Candida
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91091—Glycosyltransferases (2.4)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/9116—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • G01N2333/91165—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5) general (2.5.1)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
AT97921143T 1996-04-11 1997-04-11 Assays und reaganzien zur identifizierung von fungiziden wirkstoffen und ihre verwendungen ATE220110T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/631,319 US6117641A (en) 1996-04-11 1996-04-11 Assays and reagents for identifying anti-fungal agents and uses related thereto
US08/771,212 US6455281B1 (en) 1996-04-11 1996-12-20 Nucleic acids for identifying anti-fungal agents, and uses related thereto
PCT/US1997/005987 WO1997038293A2 (en) 1996-04-11 1997-04-11 Assays and reagents for identifying anti-fungal agents, and uses related thereto

Publications (1)

Publication Number Publication Date
ATE220110T1 true ATE220110T1 (de) 2002-07-15

Family

ID=27091358

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97921143T ATE220110T1 (de) 1996-04-11 1997-04-11 Assays und reaganzien zur identifizierung von fungiziden wirkstoffen und ihre verwendungen

Country Status (9)

Country Link
US (2) US6277564B1 (de)
EP (1) EP0892854B1 (de)
JP (1) JP2001513622A (de)
KR (1) KR20000005397A (de)
AT (1) ATE220110T1 (de)
AU (1) AU717165B2 (de)
CA (1) CA2251593A1 (de)
DE (1) DE69713759T2 (de)
WO (1) WO1997038293A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117641A (en) 1996-04-11 2000-09-12 Mitotix, Inc. Assays and reagents for identifying anti-fungal agents and uses related thereto
AU717165B2 (en) 1996-04-11 2000-03-16 Gpc Biotech Inc. Assays and reagents for identifying anti-fungal agents, and uses related thereto
US6727082B1 (en) 1996-04-11 2004-04-27 Gpc Biotech Inc. Assays and reagents for identifying anti-fungal agents, and uses related thereto
WO1998018927A1 (en) * 1996-10-30 1998-05-07 National Research Council Of Canada Candida albicans proteins associated with virulence and hyphal formation and uses thereof
JPH11103862A (ja) * 1997-10-01 1999-04-20 Takara Shuzo Co Ltd 抗原タンパク質及び該タンパク質をコードする核酸
CA2322662A1 (en) * 1998-03-13 1999-09-16 Mitotix, Inc. Assays and reagents for identifying anti-fungal agents, and uses related thereto
US6423519B1 (en) * 1998-07-15 2002-07-23 Gpc Biotech Inc. Compositions and methods for inhibiting fungal growth
US6720139B1 (en) * 1999-01-27 2004-04-13 Elitra Pharmaceuticals, Inc. Genes identified as required for proliferation in Escherichia coli
US6589738B1 (en) 1999-11-09 2003-07-08 Elitra Pharmaceuticals, Inc. Genes essential for microbial proliferation and antisense thereto
US6783985B1 (en) 2000-02-18 2004-08-31 Elitra Pharmaceuticals Inc. Gene disruption methodologies for drug target discovery
US20030180953A1 (en) * 2000-12-29 2003-09-25 Elitra Pharmaceuticals, Inc. Gene disruption methodologies for drug target discovery
WO2002086090A2 (en) * 2001-04-23 2002-10-31 Elitra Pharmaceuticals, Inc. Identification of essential genes of aspegillus fumigatus and methods of use
US20040029129A1 (en) * 2001-10-25 2004-02-12 Liangsu Wang Identification of essential genes in microorganisms
US20030170694A1 (en) * 2001-12-21 2003-09-11 Daniel Wall Stabilized nucleic acids in gene and drug discovery and methods of use
AU2003274897A1 (en) * 2002-07-10 2004-01-23 Stratagene California Humanized renilla reniformis green fluorescent protein as a scaffold
KR100914749B1 (ko) 2002-12-31 2009-08-31 엘지디스플레이 주식회사 구동회로를 포함하는 반사형 액정 표시 장치

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59212439A (ja) 1983-05-19 1984-12-01 Taisho Pharmaceut Co Ltd スチレン誘導体
JP2971894B2 (ja) * 1988-08-10 1999-11-08 武田薬品工業株式会社 Ｃ―キナーゼの酵母による製造法
AU7556991A (en) 1990-03-15 1991-10-10 Board Of Regents, The University Of Texas System Recombinant beta -1,4 glucan synthase proteins
US5202456A (en) 1991-04-15 1993-04-13 The President And Fellows Of Harvard College Compounds for inhibition of protein methylation
IL99628A (en) 1991-10-02 2004-07-25 Yissum Res Dev Co Processes for the preparation of cyclic peptides, and pharmaceutical compositions containing them
CA2080158A1 (en) 1991-10-11 1993-04-12 Scott A. Biller Method for blocking neoplastic transformation of cells induced by ras oncogenes employing bisphosphonates or analogs thereof
WO1994001126A1 (en) 1992-07-14 1994-01-20 President And Fellows Of Harvard College Compounds for inhibition of proteolysis
GB9226065D0 (en) 1992-12-14 1993-02-10 Ici Plc Peptides
US5602184A (en) 1993-03-03 1997-02-11 The United States Of America As Represented By Department Of Health And Human Services Monoterpenes, sesquiterpenes and diterpenes as cancer therapy
CA2118985A1 (en) 1993-04-02 1994-10-03 Dinesh V. Patel Heterocyclic inhibitors of farnesyl protein transferase
EP0621342A1 (de) 1993-04-20 1994-10-26 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Reagenz und Testsatz zum Nachweis oder zur Hemmung von isoprenylierender Aktivität
EP0698015A1 (de) 1993-05-14 1996-02-28 Genentech, Inc. Inhibitoren der farnesyl protein-transferase
IL109615A (en) 1993-05-17 2000-12-06 Fujisawa Pharmaceutical Co Cyclic polypeptide derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
US5602098A (en) 1993-05-18 1997-02-11 University Of Pittsburgh Inhibition of farnesyltransferase
US5705686A (en) 1993-05-18 1998-01-06 University Of Pittsburgh Inhibition of farnesyl transferase
CA2173956C (en) * 1993-10-12 2008-10-07 Cameron M. Douglas Dna encoding 1,3-beta-d glucan synthase subunits
US5721236A (en) 1993-10-15 1998-02-24 Schering Corporation Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
IL111235A (en) 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
KR100378615B1 (ko) 1993-10-25 2003-10-10 파크데이비스앤드캄파니 단백질:파르네실트랜스퍼라제의치환된테트라및펜타펩티드억제제
IL107587A (en) 1993-11-12 1998-08-16 Univ Ramot Farnesyl geranyl or geranyl-geranyl derivatives pharmaceutical compositions containing them and methods for their preparation
US5539132A (en) 1994-01-24 1996-07-23 Johns Hopkins University Cerulenin compounds for fatty acid synthesis inhibition
US5470832A (en) 1994-01-31 1995-11-28 Merck & Co., Inc. Inhibitors of geranylgeranyl-protein transferase
US5580979A (en) 1994-03-15 1996-12-03 Trustees Of Tufts University Phosphotyrosine peptidomimetics for inhibiting SH2 domain interactions
JP3969737B2 (ja) 1994-03-15 2007-09-05 エーザイ株式会社 イソプレニルトランスフェラーゼ阻害剤
CA2143588A1 (en) 1994-03-24 1995-09-25 Rajeev Bhide Inhibitors of farnesyl protein transferase
US5510510A (en) 1994-05-10 1996-04-23 Bristol-Meyers Squibb Company Inhibitors of farnesyl protein transferase
US5541181A (en) 1994-05-26 1996-07-30 Bristol-Myers Squibb Company Compound produced by a strain of micromonospora
US5484724A (en) 1994-05-26 1996-01-16 Merck & Co., Inc. DNA encoding GLSI
US5574025A (en) 1994-10-26 1996-11-12 Merck & Co., Inc. Inhibitors of prenyl-protein transferases
US5606043A (en) 1994-11-03 1997-02-25 The Regents Of The University Of California Methods for the diagnosis of glaucoma
WO1996017623A1 (fr) 1994-12-09 1996-06-13 Banyu Pharmaceutical Co., Ltd. Medicament contre le sida
JP3929069B2 (ja) 1995-01-12 2007-06-13 ユニバーシティ オブ ピッツバーグ プレニルトランスフェラーゼの阻害剤
US5684013A (en) 1995-03-24 1997-11-04 Schering Corporation Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
US5624936A (en) 1995-03-29 1997-04-29 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
IL117797A0 (en) 1995-04-07 1996-08-04 Pharmacopeia Inc Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
DE69620292T2 (de) 1995-05-31 2002-11-21 Shell Internationale Research Maatschappij B.V., Den Haag/S'gravenhage Copolyester Zusammensetzung
US5723686A (en) 1995-08-03 1998-03-03 Phillips Petroleum Company Recycle of alcohol in a combined hydroisomerization and etherification process
GB2306646A (en) 1995-10-30 1997-05-07 Merck & Co Inc Assay for compounds which inhibit ras oncogene activity involving farnesyl-protein transferase
WO1997017070A1 (en) 1995-11-06 1997-05-15 University Of Pittsburgh Inhibitors of protein isoprenyl transferases
CA2238081A1 (en) 1995-11-22 1997-05-29 S. Jane Desolms Inhibitors of farnesyl-protein transferase
IT1276162B1 (it) 1995-11-23 1997-10-27 Baldacci Lab Spa Geranilgeranil-derivati,procedimento per la loro preparazione e relative composizioni farmaceutiche
EP0879279A4 (de) 1996-02-06 2000-07-12 Lilly Co Eli Diabetestherapie
US6011029A (en) 1996-02-26 2000-01-04 Bristol-Myers Squibb Company Inhibitors of farnesyl protein transferase
AU717165B2 (en) 1996-04-11 2000-03-16 Gpc Biotech Inc. Assays and reagents for identifying anti-fungal agents, and uses related thereto
EP0952842A2 (de) 1996-04-18 1999-11-03 Merck & Co., Inc. Verfahren zur behandlung von krebs

Also Published As

Publication number Publication date
WO1997038293A3 (en) 1997-12-04
DE69713759T2 (de) 2003-03-13
WO1997038293A2 (en) 1997-10-16
EP0892854A2 (de) 1999-01-27
US6271197B1 (en) 2001-08-07
DE69713759D1 (de) 2002-08-08
EP0892854B1 (de) 2002-07-03
US6277564B1 (en) 2001-08-21
AU717165B2 (en) 2000-03-16
CA2251593A1 (en) 1997-10-16
KR20000005397A (ko) 2000-01-25
AU2726597A (en) 1997-10-29
JP2001513622A (ja) 2001-09-04

Similar Documents

Publication Publication Date Title
ATE220110T1 (de) Assays und reaganzien zur identifizierung von fungiziden wirkstoffen und ihre verwendungen
DE69935314D1 (de) Quantitatitative bestimmung von nucleinsäure-amplifizierungsprodukten
Longtine et al. The septins: roles in cytokinesis and other processes
Chen et al. Initial binding of preproteins involving the Toc159 receptor can be bypassed during protein import into chloroplasts
EP1067949A4 (de) Sequenz und verfahren zur gentechnischen herstellung von proteinen mit zellmembran translozierender aktivität.
EP1131333A4 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
DE69517010D1 (de) Ubiquitin-konjugierende enzyme
DE69831224D1 (de) Immuntoxine, die ein onc protein enthalten, gegen bösartige zellen
ATE377654T1 (de) Ubiquitin-ligase-assay
DE69831083D1 (de) Reprimiertes trans-aktivatorsystem zur charakterisierung von protein-protein interaktionen
NO20014584D0 (no) Proteinisolering og -analyse
WO2003052110A3 (en) Nucleic acid nematicides
CA2413156A1 (en) Expression vectors
AU5143099A (en) Protein fragment complementation assays for the detection of biological or drug interactions
WO2000068414A3 (en) Whole cell assay for cathepsin k
WO2001056456A3 (en) Methods and compositions for detection of disease
DE59813664D1 (de) Verfahren zum screening von antimykotisch wirkenden substanzen
ATE434936T1 (de) Tsg101-gag-wechselwirkung und ihre verwendung
WO1999046286A3 (en) Assays and reagents for identifying anti-fungal agents, and uses related thereto
WO1999011799A3 (en) Human aminopeptidase p gene
EP1058737A4 (de) Fdrg protein und nukleisäuremoleküle und ihre verwendung
TR200003695T2 (tr) Anjiyostatin bağlayıcı protein.
ATE364616T1 (de) Nucleinsäuremolekül, kit und verwendung
SE9900615L (sv) Metod och kit för tidig förutsägelse av cancer
ATE304549T1 (de) Menschliches netrin-1

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties